RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
188 hedge funds and large institutions have $411M invested in Revance Therapeutics, Inc. in 2024 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 60 increasing their positions, 54 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
3% less funds holding
Funds holding: 193 → 188 (-5)
36% less capital invested
Capital invested by funds: $644M → $411M (-$233M)
Holders
188
Holding in Top 10
2
Calls
$4.96M
Puts
$2.92M
Top Buyers
| 1 | +$13.1M | |
| 2 | +$9.87M | |
| 3 | +$9.72M | |
| 4 |
SCM
Suvretta Capital Management
New York
|
+$7.87M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$7.55M |
Top Sellers
| 1 | -$9.07M | |
| 2 | -$7.63M | |
| 3 | -$7.33M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$4.43M |
| 5 |
IHAM
Integral Health Asset Management
New York
|
-$3.96M |